We first tested whether BCBM cancer cells specifically export BCRP substrates by subjecting organoids derived from BCBM and paired primary breast tumors to in vitro treatment with topotecan, another BCRP-specific substrate (39). This evidence concerns the gene ABCG2 and cancer.